Ozempic, Wegovy, Mounjaro & Zepbound
No payout yet
This case is still being litigated — there’s no settlement fund, so there’s nothing to claim yet. We’ll notify you if that changes.
What Happened?
Patients have filed lawsuits alleging that GLP-1 medications including Ozempic, Wegovy, Mounjaro, and Zepbound caused non-arteritic anterior ischemic optic neuropathy (NAION), which can result in sudden and permanent vision loss. Plaintiffs allege the manufacturers failed to adequately warn patients and doctors about the risk. The manufacturers dispute the allegations.
Could Ozempic, Wegovy, Mounjaro & Zepbound Owe Me Money?
Possibly, but not yet. No settlement has been reached, so there’s no fund and no fixed amount — Payouts range from $20K-$50K.
If the case settles or a court rules in the class’s favor, we’ll show the real payout terms here and notify everyone on the waitlist.
Who Might This Case Cover?
- If you used Ozempic, Wegovy, Mounjaro, or Zepbound in the United States and were diagnosed with NAION resulting in vision loss during the time period to be determined.
Case details
- Case
- TBD
- Court
- TBD
- Settlement administrator
- TBD
- Final approval hearing
- TBD
Legal notice
There's no claim form for this case yet because it hasn't settled. Joining the waitlist doesn't cost anything and doesn't submit anything on your behalf.Claim is not affiliated with any class action administrator, law firm, or court.